Trinity Biotech PLC (TRIB)
1.69
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
1.69
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Enterprise Value: 91.66M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 91.66M |
| November 01, 2024 | 91.66M |
| October 31, 2024 | 92.33M |
| October 30, 2024 | 93.37M |
| October 29, 2024 | 94.79M |
| October 28, 2024 | 96.49M |
| October 25, 2024 | 93.93M |
| October 24, 2024 | 92.99M |
| October 23, 2024 | 90.34M |
| October 22, 2024 | 90.34M |
| October 21, 2024 | 91.09M |
| October 18, 2024 | 91.85M |
| October 17, 2024 | 92.28M |
| October 16, 2024 | 92.51M |
| October 15, 2024 | 91.59M |
| October 14, 2024 | 91.95M |
| October 11, 2024 | 94.60M |
| October 10, 2024 | 92.80M |
| October 09, 2024 | 92.04M |
| October 08, 2024 | 90.38M |
| October 07, 2024 | 88.54M |
| October 04, 2024 | 87.02M |
| October 03, 2024 | 86.65M |
| October 02, 2024 | 86.84M |
| October 01, 2024 | 86.74M |
| Date | Value |
|---|---|
| September 30, 2024 | 86.08M |
| September 27, 2024 | 85.98M |
| September 26, 2024 | 86.55M |
| September 25, 2024 | 86.93M |
| September 24, 2024 | 87.50M |
| September 23, 2024 | 87.50M |
| September 20, 2024 | 87.69M |
| September 19, 2024 | 87.78M |
| September 18, 2024 | 89.86M |
| September 17, 2024 | 90.81M |
| September 16, 2024 | 91.00M |
| September 13, 2024 | 90.81M |
| September 12, 2024 | 91.09M |
| September 11, 2024 | 91.00M |
| September 10, 2024 | 91.76M |
| September 09, 2024 | 92.42M |
| September 06, 2024 | 92.42M |
| September 05, 2024 | 92.33M |
| September 04, 2024 | 92.14M |
| September 03, 2024 | 92.70M |
| August 30, 2024 | 94.50M |
| August 29, 2024 | 94.50M |
| August 28, 2024 | 96.21M |
| August 27, 2024 | 99.33M |
| August 26, 2024 | 94.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
62.58M
Minimum
Nov 27 2023
197.06M
Maximum
Feb 16 2021
97.83M
Average
95.20M
Median
May 16 2023
Enterprise Value Benchmarks
| Amarin Corp PLC | -55.52M |
| DBV Technologies SA | 9.250M |
| Ascendis Pharma AS | 7.950B |
| Cellectis SA | -52.07M |
| Adaptimmune Therapeutics PLC | 18.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.757M |
| Revenue (Quarterly) | 15.84M |
| Total Expenses (Quarterly) | 17.51M |
| EPS Diluted (Quarterly) | -0.726 |
| Gross Profit Margin (Quarterly) | 36.19% |
| Profit Margin (Quarterly) | -42.65% |
| Earnings Yield | -159.5% |
| Normalized Earnings Yield | -153.85 |